Yuvell
Quick facts
Marketed products
- Letybo® · Oncology
Letybo is a tyrosine kinase inhibitor that targets FLT3 and other kinases to inhibit leukemic cell proliferation.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: